Robot suit helps MS patients walk better?

NCT ID NCT06615947

Completed Symptom relief Sponsor: Multiple Sclerosis Center of Catalonia Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a robotic walking system called Atalante could help people with multiple sclerosis walk better. Sixty participants were randomly assigned to either use the robot or receive standard physical therapy for 8 weeks. The main goal was to see if the robot improved walking speed more than conventional rehab.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Atalante self-balancing walking system (robotic exoskeleton)
What this could lead to: If successful, this could offer a new, more effective way to improve walking speed and mobility for people with multiple sclerosis.
What could go wrong: This is a small, completed trial with 60 participants. The results may not apply to all MS patients, and the exoskeleton may not be widely available or affordable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GAIT DISORDERS, NEUROLOGIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Gait Disorders, Neurologic multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GAIT DISORDERS, NEUROLOGIC MULTIPLE SCLEROSIS

Contacts and locations

Locations

Centre d'Esclerosi Mútiple de Catalunya (Cemcat) - Barcelona, Hospital Universitari Vall d'Hebron

Barcelona, Barcelona, 08035, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.